General Assembly Raised Bill No. 7078
January Session, 2017 LCO No. 3981
*03981_______GL_*
Referred to Committee on GENERAL LAW
Introduced by:
(GL)
General Assembly
Raised Bill No. 7078
January Session, 2017
LCO No. 3981
*03981_______GL_*
Referred to Committee on GENERAL LAW
Introduced by:
(GL)
AN ACT CONCERNING THE DEPARTMENT OF CONSUMER PROTECTION AND STERILE COMPOUNDING IN INSTITUTIONAL PHARMACIES.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. Subsection (a) of section 20-633b of the general statutes is repealed and the following is substituted in lieu thereof (Effective July 1, 2017):
(a) As used in this section:
(1) "Medical order" means a written, oral or electronic order by a prescribing practitioner, as defined in section 20-14c, for a drug to be dispensed by a pharmacy for administration to a patient;
(2) "Sterile compounding pharmacy" means a pharmacy, as defined in section [20-594, or] 20-571, a nonresident pharmacy registered pursuant to section 20-627, or an institutional pharmacy, as defined in section 20-571, that dispenses or compounds sterile pharmaceuticals; and
(3) "Sterile pharmaceutical" means any dosage form of a drug, including, but not limited to, parenterals, injectables, surgical irrigants and ophthalmics devoid of viable microorganisms.
This act shall take effect as follows and shall amend the following sections:
Section 1 July 1, 2017 20-633b(a)
This act shall take effect as follows and shall amend the following sections:
Section 1
July 1, 2017
20-633b(a)
Statement of Purpose:
To clarify that the Department of Consumer Protection has regulatory authority over sterile compounding within institutional pharmacies.
[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]